Author: Daniel S, PhD
"Dear Friends: Some weeks ago I’ve got a question if complete remission from Stage 4 cancers is actually possible at all. My answer was: Yes! There are two major categorise of complete remissions:
1. spontaneous complete remissions – there are many cases of spontaneous remissions reported in the scientific literature often due to unknown causes
2. complete remissions following treatments – these can be achieved with both conventional therapies as well as with new and alternative therapies including supplements, re-purposed drugs, diet and other less conventional approaches.
In this post I would like to address the second category and list 10 case reports published in the scientific literature (i.e. not anecdotal reports) showing that complete remission can be induced even when conventional medicine alone cannot add much value. Some of these case reports have been already shared by contributors on this website or myself, but is good to have a consolidated list of several of them.
There are many more case reports (some already shared in the past posts on this website) that are impressive, but I had to stop somewhere. I could not stop easily so I had to share a few more cases at the end of this post. If you are aware of impressive case reports published in peer review journals, please share them as comments at the end of this post, so we can continue learning from each other.
Cancer seems to be a complex problem. However that is because we do not understand it well. Any problem in life has a simple solution, and from time to time nature sends us signals exposing its simplicity. We need to see those signs and start looking for patterns, and this is the first step towards finding a solution to our challenges.
Case 1: Metastatic Colorectal Cancer Complete Remissions with Irbesartan
A case report by MDs and scientists at British Columbia Cancer Agency, Canada’s Michael Smith Genome Sciences Centre, Vancouver; Department of Medical Genetics, University of British Columbia, Vancouver; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver; Department of Molecular Biology and Biochemistry, Simon Fraser University, Vancouver, Canada
A 67-year-old female, not tolerating adjuvant chemotherapy presented constant recurrence of a colorectal cancer stage 4. Genomic analysis and prior literature in colorectal cancers indicated that angiotensin blockade may inhibit a part of colorectal cancers. Supported by these findings, her doctors suggested that irbesartan could be a potential option due to the blockade of the renin–angiotensin pathway.
The patient had a pretreatment baseline PET/CT scan and started Irbesartan at a dose of 150 mg daily. She had a follow-up PET/CT at 5 weeks and again at 3 months (Figure B to E). Before the therapy, her CEA was elevated at 18 (upper limit of normal 5). After 5 weeks of therapy, this value decreased to a CEA of 3.1. Furthermore, there was virtually a complete functional radiological resolution of her disease (Figure D and E). These results are maintained at the 10-month point with CEA at 1.4.
Irbesartan, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a drug that is both available and accessible (i.e. cheap).
Case 2: Chronic Lymphocytic Leukemia Complete Remission with EGCG from Green Tea Extract . . . "
Full Article: https://www.cancertreatmentsresearch.co ... sed-drugs/